• Sonuç bulunamadı

Clinical Practice Guidelines

N/A
N/A
Protected

Academic year: 2021

Share "Clinical Practice Guidelines"

Copied!
8
0
0

Yükleniyor.... (view fulltext now)

Tam metin

(1)

PHM 3525 Drug Information

Ankara University Faculty of Pharmacy Department of Clinical Pharmacy

(2)

Clinical Practice Guidelines

Definition: Guidelines are systematically developed statements created

to assist practitioner and patient decisions

about healthcare for specific circumstances

2

(3)

Why there is a need?

Improve healthcare quality

Improve patient outcomes

3

(4)

History

Clinical Practice Guideline is a fairly recent phenomenon.

The first diabetes guidelines from the ADA were published in 1988.

4

(5)

Development Strategies

Produce guidelines that are accurate

Provide recommendations that are accountable

Facilitate application of policy

5

(6)

Development Methods

Consensus method:

Evidence based method:

6

(7)

Pharmacists’ Critical Assessment

What are the recommendations?

Are the recommendations valid?

Will the recommendations help me in caring for my patients?

7

(8)

Conclusion

Pharmacists must possess deeper expertise

enables them to function beyond the recommendations

creates masterful pharmacotherapeutic plans.

8

Referanslar

Benzer Belgeler

Teachers explained the concept of clinical practice in terms of the importance of teacher education, the characteristics of future teachers, the importance of collaboration

We also found that pediatricians were aware of their lack of knowledge and willing to receive postgraduate education on chronic cough management.A national cough

Each paper should have a title page (cover page) where the title of the paper, name of the student, student number and the date of submission is indicated.. The essay can be

As defined by the Institute of Medicine (IOM) and the Agency for Health Care Policy and Research (AHCPR), practice guidelines are “systematically developed statements to

This effectively means that metformin stays as the first-line drug in patients with T2DM without CVD, and in patients at moderate CV risk, while in patients at high/very-high CV

Epi- cardial fat tissue thickness correlates with endothelial dysfunction and other cardiovascular risk factors in patients with metabolic syndrome.. Çetin M, Cakıcı M, Polat M,

We would like to thank you for your comments on our ar- ticle (1) entitled “The first six-month clinical outcomes and risk factors associated with high on-treatment platelet

For patients with PAH at low or interme- diate risk status, two treatment strategies, either initial mono- therapy with approved PAH drugs or oral upfront combination therapy,